• Meta-Analysis of Mortality In Adults, Newborns and Older Children With Bacterial Infections And Sepsis When Treated By Igm-Enriched Intravenous Immunoglobulins And Standard Schemes

    Nov 1, 2015, 00:00
  • Rectal Culture Testing Before Transrectal Ultrasound-Guided Prostate Biopsy (Trusbx) In Hong Kong – A Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00
  • Health-Related Quality of Life (Hrqol) In Splenectomized Immune Thrombocytopenia (Itp) Patients – A Targeted Literature Review

    Nov 1, 2015, 00:00
  • The Effect of Szigetvár Thermal Water on Quality of Life of Patients With Rheumatic Diseases

    Nov 1, 2015, 00:00
  • Budget Impact Analysis of Apremilast In Patients With Psoriatic Arthritis In Spain

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of Bortizomib For Multiple Myeloma- A Systematic Review

    Nov 1, 2015, 00:00
  • Health Services Utilization By Dengue Patient In Brazil, 2012 – 2013- A Multicenter Study

    Nov 1, 2015, 00:00
  • Quantitative Assessment of Canadian Provincial Public Funding Decisions for Oncology Drugs Following Pcodr Economic Evaluations for 2013 and 2014

    Nov 1, 2015, 00:00
  • Identifying The Optimal Use Of Ctcs In The Early Staging Phase Of Breast Cancer

    Nov 1, 2015, 00:00
  • The South African Guidelines for Pharmacoeconomic Submissions- A Review In Context of Existing Legislation and Challenges to Implementation

    Nov 1, 2015, 00:00
  • Análisis Del Modelo de Toma de Decisiones Sobre Cobertura de Medicamentos en Chile

    Nov 1, 2015, 00:00
  • Impact of Genetic Factors on Gastrointestinal Bleeding in a Prospective Cohort of new Warfarin users

    Nov 1, 2015, 00:00
  • Gender Differences in Medication Taking Behaviour- A Case of Osteoporosis

    Nov 1, 2015, 00:00
  • Indirect Comparison for E/C/F/Taf In Treatment Naïve Hiv Patients

    Nov 1, 2015, 00:00
  • Economic Evaluation for The Decision Making Process of Implementing of Pharmaceutical Care for The Treatment of Hypertension In The Brazilian Health System- Stage I - Direct-Costs Analysis

    Nov 1, 2015, 00:00
  • How are Pain Treatment Response Rates In Primary Care Influenced By Co-Prescription of Cyp2d6 Inhibitors?

    Nov 1, 2015, 00:00
  • Diagnosis And Management of Moderate-To-Severe Irritable Bowel Syndrome With Constipation (Ibs-C) In Germany- Results From The Ibis-C Study

    Nov 1, 2015, 00:00
  • Do Free Medications Improve Observance Among Diabetic Patients?

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of Nilotinib In Patients With Chronic Myeloid Leukaemia Eligible To Start The Treatment-Free Remission Phase In Italy

    Nov 1, 2015, 00:00
  • Structure Of Health-Related Direct Costs In Ukraine - The First Step Of Analysis

    Nov 1, 2015, 00:00
  • Comparação De Tratamentos Para Câncer De Cabeça E Pescoço Ajustado Por Escore De Propensão- Radioterapia Versus Cirurgia+Radioterapia

    Nov 1, 2015, 00:00
  • The Budget Impact of Orphan Drugs In The Us and Canada- A 2007-2013 Midas Sales Data Analysis

    Nov 1, 2015, 00:00
  • Evaluation of The Cost Effectiveness of Rifaximin-á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In Sweden

    Nov 1, 2015, 00:00
  • Cost of Illness Analysis in Patients with Diabetic Foot Syndrome in Health Care of Republic of Belarus

    Nov 1, 2015, 00:00
  • The Oxford Participation Activities Questionnaire (Ox-Paq)- Psychometric Analysis

    Nov 1, 2015, 00:00
  • The Cost of Patients With Relapsing-Remitting Multiple Sclerosis Who Develop Neutralizing Antibodies While Treated With Interferon Beta

    Nov 1, 2015, 00:00
  • A Pilot Study Measuring Knowledge and Attitudes Towards Diabetes Mellitus In Kedah, Malaysia

    Nov 1, 2015, 00:00
  • French Physician Sensitivity To And Consideration Of The Costs Of Cancer Treatment

    Nov 1, 2015, 00:00
  • The Relative Clinical and Economic Value of Ipilimumab in the Treatment of Metastatic Melanoma Versus Other Anti-Cancer Agents for Metastatic Diseases from a Brazilian Private Health Care System Perspective

    Nov 1, 2015, 00:00
  • Correlation Between Equation For Estimating Glomerular Filtration Rate- Chronic Kidney Disease Epidemiology Collaboration -Ckd -Epi, Cockcroft-Gault -Cg- And Modification Of Diet And Renal Disease –Mdrd4- In Colombia

    Nov 1, 2015, 00:00
  • The Indirect Costs of Inflammatory Bowel Disease (Crohn’s Disease And Ulcerative Colitis) Associated With Absenteeism In Poland In 2013

    Nov 1, 2015, 00:00
  • Extension of Indication With Mature Products- Toward More Incentives Rewarding Innovation?

    Nov 1, 2015, 00:00
  • An Assessment of the Impact of Biosimilars on Access to Biologics Based on Primary Research, System Dynamics Modelling, and War Gaming

    Nov 1, 2015, 00:00
  • An Analysis of German G-BA Added Benefit Assessment Decisions Using the World Health Organization Daly Framework

    Nov 1, 2015, 00:00
  • The Burden of Obesity in Mexico- Prevalence, Comorbidities, and Associations With Quality of Life, Resource Utilization and Productivity

    Nov 1, 2015, 00:00
  • Towards Creating A National System of Care for Patients With Orphan Diseases

    Nov 1, 2015, 00:00
  • Use of Simulation to Assess the Impact of a Remote Monitoring System

    Nov 1, 2015, 00:00
  • Selective Retina Therapy

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis Of Pertuzumab For Metastatic Her2-Positive Breast Cancer In Japan

    Nov 1, 2015, 00:00
  • Analysis of Eribulin Mesylate Utilzation in Patients with Metastatic Breast Cancer (Mbc) by Line of Therapy and Associated Changes Over Time

    Nov 1, 2015, 00:00
  • The Cost of Vaccination Throughout Life- A Pan-European Perspective

    Nov 1, 2015, 00:00
  • Evaluation Of ‘Real-World’ Ipilimumab Data In Ireland

    Nov 1, 2015, 00:00
  • Study on Quality of Nursing Care and Assessment of Safety

    Nov 1, 2015, 00:00
  • Effects of Financial Incentives for Saving Drug Expenditures on Physician Prescription Behaviors

    Nov 1, 2015, 00:00
  • Dynamics of Public Outpatient Drug Expenditures in Austria, 2005-2015

    Nov 1, 2015, 00:00
  • Nocturia Work Productivity And Activity Impairment Compared To Other Common Chronic Diseases- A Systematic Review

    Nov 1, 2015, 00:00
  • Qualitative and Quantitative Analysis of The Scottish Medicines Consortium (Smc) Advice

    Nov 1, 2015, 00:00
  • The Efficacy and Safety of Abatacept, Adalimumab, Etanercept And Tocilizumab are Comparable In Polyarticular Juvenile Idiopathic Arthritis

    Nov 1, 2015, 00:00
  • Considering Evidence From Health Economics Within Immunization Decision-Making - A Semi Multiple Criteria Decision Approach Using The Decide Tool

    Nov 1, 2015, 00:00
  • The Comparative Pharmacoeconomic Analysis Of Using Plerixafor For Stem Cell Mobilization For Autologous Peripheral Stem Cell Transplantation For Non-Hodgkin’s Lymphoma Patients

    Nov 1, 2015, 00:00
  • Pharmacoeconomic Analysis Of Anidulafungin, Micafungin, Caspofungin And Fluconazole In The Treatment Of Candidemia And/Or Invasive Candidiasis In Non-Neutropenic Adult Patients In Spain

    Nov 1, 2015, 00:00
  • Cost-Utility of Ranibizumab Versus Aflibercept for Treating Visual Impairment Due to Diabetic Macular Edema In Greece

    Nov 1, 2015, 00:00
  • Network Meta-Analysis to Assess Comparative Effectiveness of Beta-Blockers in Patients with Heart Failure and Reduced Ejection Fraction

    Nov 1, 2015, 00:00
  • Economic Evaluation of Fecal Microbiota Transplantation for The Treatment of Recurrent Clostridium Difficile Infection In Australia

    Nov 1, 2015, 00:00
  • The Impact of Societal Views on Market Access- Case Studies For Utilization of Hpv Vaccines in Cervical Cancer and Prep Hiv Preventive Therapy

    Nov 1, 2015, 00:00
  • Value Assessment for Genetic Testing of Drug Variation In An Elderly Population

    Nov 1, 2015, 00:00
  • Introduction of Formal Risk Sharing Agreements (Rsa)- A Promising Solution for Sustainable and Predictable Pharmaceutical Expenditures In Bulgaria

    Nov 1, 2015, 00:00
  • Are Spanish Regions Implementing The National Therapeutic Positioning Report (Tpr) Regarding New Oral Anticoagulants (Noac) In The Same Way? A Case Of Regional Variability In Drug Access

    Nov 1, 2015, 00:00
  • How Can Biosimilars Compete with Existing Biologics- update of the Results of a Previous Study

    Nov 1, 2015, 00:00
  • The Impact Of Pharmaceutical Innovation On Premature Cancer Mortality In Portugal

    Nov 1, 2015, 00:00
  • Shaping European Early Dialogues- The Seed Project

    Nov 1, 2015, 00:00
  • Therapeutic and Economic Value of Everolimus Plus Exemestane for the Treatment of Postmenopausal Women with Hormone Receptor-Positive, Her2/Neu Negative Advanced Breast Cancer

    Nov 1, 2015, 00:00
  • The Use of Mobile Health Technology in Promoting Infant Vaccine Adherence – A Health Technology Assessment

    Nov 1, 2015, 00:00
  • Analysis of Cost Minimization of Adalimumab Compared With Infliximab for The Treatment of Ulcerative Colitis In The Public Market In Mexico

    Nov 1, 2015, 00:00
  • Development of a Prediction Model of Disease Activity in Support of Clinical Practice – the Acrodat Experience

    Nov 1, 2015, 00:00
  • Hospitalization Costs of Type 2 Diabetes Mellitus (T2dm) Patients In A Public Hospital In Brazil

    Nov 1, 2015, 00:00
  • A Comprehensive Disease Model of Polycystic Ovary Syndrome (Pcos)

    Nov 1, 2015, 00:00
  • How Pharmaceutical Cost Indicators Are Affected When Adjusted To Hospitals’ Clinical Workload- Data Analysis For Greek Nhs Hospitals

    Nov 1, 2015, 00:00
  • Heart Failure Management- A Nationwide Population-Based Cohort Study Using The French Egb Database

    Nov 1, 2015, 00:00
  • Potential Long-Term Cost Savings In Treatment of Naïve Hiv-Infected Patients With Rilpivirine/ Tenofovir/ Emtricitabine (Single Tablet Regimen) In The Russian Federation

    Nov 1, 2015, 00:00
  • A Perspective on the use of Health Technology Assessment in Brazil and Mexico

    Nov 1, 2015, 00:00
  • COST-EFFECTIVENESS AND FEASIBILITY OF IMPLEMENTING MRI-GUIDED NEOADJUVANT CHEMOTHERAPY TO TREAT ER-POSITIVE HER2-NEGATIVE BREAST CANCERS IN THE NETHERLANDS

    Nov 1, 2015, 00:00
  • Using The Transtheoretical Model to Enhance Self-Management Activities In Type 2 Diabetic Patients- A Systematic Review

    Nov 1, 2015, 00:00
  • Economic Evaluation Of The Rotavirus Vaccination Among Children Under 5 Years Of Age In Switzerland

    Nov 1, 2015, 00:00
  • Economic Modelling Studies Published In 2014- Which Disease Areas Have Been The Main Focus Of Clinical Research?

    Nov 1, 2015, 00:00
  • Modeling The Cost-Effectiveness of The All Oral, Direct-Acting Antiviral Regimen Daclatasvir Plus Sofosbuvir In Patients Co-Infected With Hepatitis C Virus (Hcv) And Hiv

    Nov 1, 2015, 00:00
  • Benefícios Materiais Como Incentivo Para Redução de Abandono de Tratamento de Tuberculose em Pessoas Vivendo em Situação de Rua- Revisão de Análises Econômicas

    Nov 1, 2015, 00:00
  • Anemia Treatment Cost in Patients with Chronic Kidney Disease (A-Ckd) In The Mexican Social Security Institute (Imss)

    Nov 1, 2015, 00:00
  • Higher Drug Survival Rates in Patients with Psoriasis Utilizing Etanercept Compared to Adalimumab – a Nationwide Population-Based Cohort Study in Sweden

    Nov 1, 2015, 00:00
  • Analisis De Costo-Efectividad De La Educacion De Pacientes Con Diabetes Tipo 2 Por Pares

    Nov 1, 2015, 00:00
  • Mammography For Breast Cancer Screening In India – A Health Technology Assessment

    Nov 1, 2015, 00:00
  • Sipuleucel-T (Provenge®)- Autopsy of an Innovative Change of Paradigm in Cancer Treatment

    Nov 1, 2015, 00:00
  • Pharmacovigilance in Oncology- Knowledge and Perception on Adverse Events Reporting in Brazil

    Nov 1, 2015, 00:00
  • The Economic Aspect Of Warfarin Pharmacogenetics Introduction Into Health System

    Nov 1, 2015, 00:00
  • Effectiveness and Side Effects of Oseltamivir for Influenza Treatment- A Meta-Analysis of Meta-Analysis

    Nov 1, 2015, 00:00
  • A Mixed Treatment Comparison (Mtc) to Compare the Efficacy of Anti-Thrombotic Agents in the Acute Treatment of Venous Thromboembolism (Vte) in Patients with Active Cancer

    Nov 1, 2015, 00:00
  • Developing A Drug Price Reference Index In The Philippines

    Nov 1, 2015, 00:00
  • Closing the Gap Between Hta and Innovation Uptake in Finnish Hospitals

    Nov 1, 2015, 00:00
  • Adherence to Antiretroviral Therapy Among Patients Lost-To-Follow Up- A Case of An Hiv Clinic in a Private-For-Profit Health Facility in Kampala, Uganda

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of Active Surveillance Of Carbapenem-Resistant Enterobacteriaceae In Intensive Care Units In Hong Kong

    Nov 1, 2015, 00:00
  • Economic Evaluation Of Tiotropium For Severe Persistent Asthma In Portugal

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of Tiotropium Vs Glycopyrronium In Moderate To Very Severe Copd In Spain

    Nov 1, 2015, 00:00
  • U.s. Payer Expectations for Reimbursement of Biosimilars

    Nov 1, 2015, 00:00
  • Impact Of Staging And Hormone Sensitivity On Quality Of Life In Us Prostate Cancer Patients

    Nov 1, 2015, 00:00
  • Economic Evaluation of Ulipristal Acetate For The Treatment of Patients With Moderate And Severe Symptoms of Uterine Fibroids Before Surgery In Mexico

    Nov 1, 2015, 00:00
  • The Effect Of Metformin Use And Mortality Among Those With Pancreatic Cancer And Type 2 Diabetes Mellitus- Findings From A Nationwide Population Retrospective Cohort Study

    Nov 1, 2015, 00:00
  • Assessing The Treatment Burden for Growth Hormone Deficiency (Ghd) In Children- Concept Elicitation Results Supporting The Development of The Treatment Burden Measure for Childhood Ghd (Tb-Cghd)

    Nov 1, 2015, 00:00
  • Characteristics of Pediatric Patients With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Agents

    Nov 1, 2015, 00:00
  • Comparison between HTA Reports in Veneto and Emilia Romagna- Drugs Assessment Decision Criteria and Priorities

    Nov 1, 2015, 00:00
  • A Concept For Best-Practice In Therapeutic Drug Monitoring (Tdm) For Kidney Transplant (K-Tx)- Results From Q-Perior Study

    Nov 1, 2015, 00:00
  • Trends of Hpv Vaccine Uptake, Completion, and Adherence in the United States- 2006-2011

    Nov 1, 2015, 00:00
  • Assessment of Consumer Likelihood to Adopt an Electronic Health Record (EHR) Mobile Application and the Impact of Perceived Risk of Privacy Leaks

    Nov 1, 2015, 00:00
  • Orphan Drug Regulation In The Usa, European Union, Japan and South Korea- A Comparative Analysis

    Nov 1, 2015, 00:00
  • Costo-Efectividad De Toracotomía Versus Videotoracoscopia En Pacientes Con Cáncer De Pulmón De Célula No Pequeña En Estadio I

    Nov 1, 2015, 00:00
  • Short And Long-Term Economic Impact of Secondary Hyperparathyroidism Treatment in Chronic Kidney Disease in Carlos Andrade Marin Hospital (Ecuador)

    Nov 1, 2015, 00:00
  • Using Active Techniques to Handle Chronic Low Back Pain Caused By Sedentary Work

    Nov 1, 2015, 00:00
  • The United States Specialty Pharmacy Payor Landscape

    Nov 1, 2015, 00:00
  • Determinants of Orphan Drug Prices in Fran Regression Analysis

    Nov 1, 2015, 00:00
  • Innovative Methods For Early Diagnostic Of Cancer

    Nov 1, 2015, 00:00
  • A Polypill Intervention To Improve Adherence For Secondary Cardiovascular Disease Prevention In Spain- A Cost-Effectiveness Study

    Nov 1, 2015, 00:00
  • Economic Analysis Of Epicup, An Epigenetic Test To Predict The Tissue Of Origin In Cancer Of Unknown Primary Site, From The Spanish Nhs Perspective

    Nov 1, 2015, 00:00
  • Cost-Minimization Analyses of Adalimumab Compared with Selective Immunosuppressive Cytokines Blockers and Inhibitors of Tumor Necrosis Factor Alpha Indicated for the Treatment of Rheumatoid Arthritis, Psoriasis and Crohn’s Disease in the Pr ...

    Nov 1, 2015, 00:00
  • Quality Of Life In Patients With Breast Cancer In Slovakia

    Nov 1, 2015, 00:00
  • Cost-Efficiency of of National Drug Information Center Through Ministry of Healh Hotline Calling Services (937) in Saudi Arabia- Application of a Mercian Model

    Nov 1, 2015, 00:00
  • Custo-Efetividade Da Cintilografia Óssea De Corpo Inteiro Na Avaliação Pre-Transplante Hepático De Pacientes Com Carcinoma Hepatocelular Na Região Sul Do Brasil

    Nov 1, 2015, 00:00
  • Prevalence And Risk Factors Of Skin Cancer In Mexico- An Observational Study

    Nov 1, 2015, 00:00
  • Recent Trends In Anaphylaxis-Related Hospitalization In The United States

    Nov 1, 2015, 00:00
  • Avoiding Anything ‘Abnormal’ in the Translation of ‘Usually’

    Nov 1, 2015, 00:00
  • Opioids Switch In Chronic Pain- Impact Assessment Using Electronic Health Records

    Nov 1, 2015, 00:00
  • Cost of Achieving Combined Improvements in HbA1c and Weight without Hypoglycaemia over 4 Years in a Post-Hoc Analysis of Dapagliflozin + MET Vs Glipizide + MET

    Nov 1, 2015, 00:00
  • A One-Year Follow-Up of Patients with Acute Coronary Syndrome (Acs) and Diabetes Treated with Statins- Outcomes and Health Care Costs Supported by Italian National Health Service

    Nov 1, 2015, 00:00
  • Association of Medication Persistency with Route of Administration and Patient Cost-Sharing- Analysis of Commonly Used Biologics

    Nov 1, 2015, 00:00
  • Economic Evaluation Of Tiotropium Administrated Through The Respimat Inhaler As Add-On Therapy In Patients With Uncontrolled Severe Asthma In Poland

    Nov 1, 2015, 00:00
  • Empirical Evidence for Identifying Best Practices in Translatability Assessment as a Proactive Tool for Enhancing the Quality of Pro and Hrqol Translation and Linguistic Validation

    Nov 1, 2015, 00:00
  • Evaluación Del Costo-Efectividad Y Costo-Utilidad Del Uso De Rivaroxabán En Pacientes Con Fibrilación Auricular No Valvular Frente A Warfarina En El Contexto Ecuatoriano

    Nov 1, 2015, 00:00
  • Basal Insulin Regimens- Systematic Review, Network Meta-Analysis, and Cost - Utility Analysis for the National Institute For Health and Care Excellence (Nice) Clinical Guideline on Type 1 Diabetes Mellitus in Adults

    Nov 1, 2015, 00:00
  • Costs of Adverse Drug Events- Systematic Review

    Nov 1, 2015, 00:00
  • Aspirin Versus Clopidogrel in Patients with Acute Myocardial Infarction- a Cost and Effectiveness Comparison from Beijing Medical Insurance Database

    Nov 1, 2015, 00:00
  • The Impact Of First-Line Tyrosine Kinase Inhibitors (Tkis) On Overall Survival In Patients With Advanced Non-Small Cell Lung Cancer (Nsclc) And Activating Epidermal Growth Factor Receptor (Egfr) Mutations- Meta-Analysis Of Major Randomized ...

    Nov 1, 2015, 00:00
  • Economic Evaluation of Children Vaccination from 2 To 18 Years of age with the Live attenuated Influenza Vaccine ComparED with the Existing Vaccines in the Portuguese Setting

    Nov 1, 2015, 00:00
  • Field Monitoring Of The Z Benefits For Breast Cancer Of The Philippine Health Insurance Corporation

    Nov 1, 2015, 00:00
  • Budget Impact Analysis of Delayed-Release Dimethylfumarate In The Treatment of Relapsing-Remitting Multiple Sclerosis In Italy

    Nov 1, 2015, 00:00
  • Comparison Of Different Costing Methods

    Nov 1, 2015, 00:00
  • Efficiency Analysis of Surgical Staplers Compared to Manual Suture for Open And Laparoscopic Surgery

    Nov 1, 2015, 00:00
  • Improvements in Workplace and Household Productivity Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naive Patients with Severe, Active and Progressive Rheumatoid Arthritis- Results from the ...

    Nov 1, 2015, 00:00
  • Adding Bevacizumab To Single-Agent Chemotherapy For The Treatment Of Platinum-Resistant Recurrent Ovarian Cancer- A Cost-Effectiveness Analysis Of The Aurelia Trial

    Nov 1, 2015, 00:00
  • Understanding The Impact Of Patient And Physician Preferences In Personalized Treatment For Melanoma Using A Discrete Choice Experiment

    Nov 1, 2015, 00:00
  • Estimation of The Progression of Colon Cancer By Japanese Large-Scale Insurance Benefits Data Analysis

    Nov 1, 2015, 00:00
  • Patient Access Schemes Within The Uk- A Retrospective Analysis

    Nov 1, 2015, 00:00
  • New Drugs In Advanced Melanoma- Disparities In Requirements For Post-Launch Real-Word Evidence In Europe

    Nov 1, 2015, 00:00
  • Regispt- Registry of Registries In Portugal

    Nov 1, 2015, 00:00
  • Life Quality of Young Adult Patients With Inflammable Bowel Disease

    Nov 1, 2015, 00:00
  • Resource Utilisation And Bleeding Events During Anticoagulation Treatment- Real-World Findings From England

    Nov 1, 2015, 00:00
  • Increasing Transparency and the Patient Voice in HTA of New Medicines

    Nov 1, 2015, 00:00
  • Economic Evaluation Of Fibrin Sealant Patch- A Proposal To Assess The Economic Value In Hemostasis And As A Surgical Sealant

    Nov 1, 2015, 00:00
  • Evaluation of the Burden of Opioid Abuse Among us Veteran Patients

    Nov 1, 2015, 00:00
  • Descripttive Evaluation of Patient Characteristics and Health Care Resource utilization of Patients Diagonsed with Breast Cancer

    Nov 1, 2015, 00:00
  • Costo De Cáncer Gástrico Avanzado En Los Establecimientos Hospitalarios Del Perú

    Nov 1, 2015, 00:00
  • Quality Of Life And Emotional Impact Of A Fixed Dose Combination Of Antihypertensive Drugs In Patients With Uncontrolled Hypertension

    Nov 1, 2015, 00:00
  • Do Access Restrictions Always Imply Cost Reduction? Case of Turkish Dpp4 Market In Treatment of Type Ii Diabetes

    Nov 1, 2015, 00:00
  • Anticoagulant Treatment After Vte In The Netherlands

    Nov 1, 2015, 00:00
  • Assessing The Level Of Resistance/Intolerance To Hydroxyurea Therapy Amongst Patients With Polycythemia Vera In Europe

    Nov 1, 2015, 00:00
  • Healthcare Associated Infections. Impact And Costs Of Diagnosis And Management Of Clostridium Difficile Infections (Cdi). The Experience Of A University Hospital In Rome

    Nov 1, 2015, 00:00
  • Defibrotide in Veno-Occlusive Disease in Public Hospitals of Paris- Funding Issues and Perspectives

    Nov 1, 2015, 00:00
  • Productivity Loss Due to Low Back Pain- Results from Swedish Registers

    Nov 1, 2015, 00:00
  • PATIENT CHARACTERISTICS AND HEALTHCARE BURDEN OF CANCER HOSPITALIZATIONS IN THE UNITED STATES

    Nov 1, 2015, 00:00
  • A Cost Comparison of Treatment with Abiraterone Acetate Plus Prednisone in the Pre Chemotherapy Setting Followed By Enzalutamide in the Post-Chemotherapy Setting Versus the Opposite Treatment Sequence in Metastatic Castration Resistant Pros ...

    Nov 1, 2015, 00:00
  • Valuation of Eq-5d Health States by Pharmacy Students in Poland (Comparison of Different Methods and with General Population)

    Nov 1, 2015, 00:00
  • Analysis of Preeclampsia Prevention in Real Practice and the Need to Improve Information Support of Doctors in Ukraine

    Nov 1, 2015, 00:00
  • Costo De Cáncer De Cuello Uterino En Los Establecimientos De Salud Del Perú

    Nov 1, 2015, 00:00
  • Cost of Familial Mediterranean Fever (Fmf) Disease In Turkey

    Nov 1, 2015, 00:00
  • Effects Of Adverse Events On Quality Of Life Scores In A Randomized Clinical Trial Of Adjuvant Chemotherapy For Breast Cancer- N-Sas Bc 02

    Nov 1, 2015, 00:00
  • The Societal and Economic Impact of Cervical Cancer in Brazil

    Nov 1, 2015, 00:00
  • Possible Applications of Real World Evidence in Safety Operations

    Nov 1, 2015, 00:00
  • Incidencia E Importes Asociados A Las Atenciones Por Hipoglicemia Grave En Pacientes Con Diabetes Mellitus Tipo 2 En Tratamiento Con Antidiabéticos Orales En Ecuador

    Nov 1, 2015, 00:00
  • Comparison Between The Interim Eq-5d-5l Score And The New Japanese Scoring In Stroke Patients

    Nov 1, 2015, 00:00
  • Are vaccines getting a fair deal? Health technology assessment of vaccines across europe

    Nov 1, 2015, 00:00
  • Observational (Obs), Pragmatic (Pra), And Indirect (Ind) Methodologies For Comparative Relative Effectiveness (Re) And Benefit-Risk (Br) Analyses

    Nov 1, 2015, 00:00
  • Racial Disparities In total ankle arthroplasty Utilization and outcomes

    Nov 1, 2015, 00:00
  • Uso De Recursos Medicos En La Intervencion De Examenes De Tamizaje Y Tratamiento De Pacientes Con Problemas Y Trastornos De Salud Mental 2012-2013

    Nov 1, 2015, 00:00
  • Translation and Linguistic Validation of the Caregiver Quality of Life Cystic Fibrosis Scale (Cqolcf) and the Multidimensional Scale of Perceived Social Support (Mspss) for use in Germany and the United Kingdom (Uk)

    Nov 1, 2015, 00:00
  • The Atlantic Divide In Coronary Heart Disease- Health Technologies Use In The Us And Portugal

    Nov 1, 2015, 00:00
  • Advanced Therapy Medicinal Products May Dramatically Impact Payers’ Budget

    Nov 1, 2015, 00:00
  • Estimating Eortc-8d Health State Utility Values From Eortc Qlq-C30 Scores In Relapsed Multiple Myeloma

    Nov 1, 2015, 00:00
  • Prma Reform in Poland – Impact on Pharmaceutical Industry and Market Access

    Nov 1, 2015, 00:00
  • Economic Burden of Chronic Spontaneous Urticaria And Psoriasis- Patients Perspective From Europe

    Nov 1, 2015, 00:00
  • Fda Breakthrough Medicines; Have They Caused Breakthrough Headaches for Hta Agencies?

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of A Fixed-Dose Combination Of Solifenacin Plus Tamsulosin Ocas For The Treatment Of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia In Spain

    Nov 1, 2015, 00:00
  • A Real-World Analysis Of Korean Nation-Wide Database- Pattern, Adherence, And Associated Heatlhcare Costs Of Imatinib Among Patients With Chronic Myeloid Leukemia

    Nov 1, 2015, 00:00
  • Pharmacoepidemiologic Modeling of Treatment Hiv-Infected Patients With Rilpivirine/ Tenofovir/ Emtricitabin (Single Tablet Regimen) in Russia

    Nov 1, 2015, 00:00
  • Avoidable Burden and Unmet Need Associated with Non-Radiographic Axial Spondyloarthritis Treatment- A Cross-Sectional European Study in the Real World Setting

    Nov 1, 2015, 00:00
  • Comparative Efficacy Of Imatinib, Dasatinib And Nilotinib For Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (Cml-Cp)- A Meta-Analysis And Indirect Comparison

    Nov 1, 2015, 00:00
  • Quality Analysis of Pharmacoeconomics Evaluation and Application Literature in China During 2009-2013

    Nov 1, 2015, 00:00
  • A Novel Itc Approach- Matching Patient-Level Data To Study-Level Summary Means And Variances

    Nov 1, 2015, 00:00
  • Increased Cost-Effectiveness Of Diagnostic Imaging In Patients With Suspected Cad By Using A New Clinical-Biohumoral Predictive Model Of Disease

    Nov 1, 2015, 00:00
  • Assessing Equity Of Health Service Utilization Of Urban Residents In China- A Case Study Of B City, Shaanxi Province

    Nov 1, 2015, 00:00
  • The Association Between Disease Activity And Indirect Costs of Absenteeism And Presenteeism Generated By Patients With Ankylosing Spondylitis In Polish Population

    Nov 1, 2015, 00:00
  • Patients’ Perception of Adherence to Therapy In Ulcerative Colitis- Results of A Survey to Specialized Centers

    Nov 1, 2015, 00:00
  • Análisis De Costo-Utilidad De Pcv13 Versus Ppsv23 En Adultos De 65 Años Y Más

    Nov 1, 2015, 00:00
  • Costo De Cáncer De Mama En Los Establecimientos De Salud Del Perú

    Nov 1, 2015, 00:00
  • Opportunistic Screening For Atrial Fibrillation In Primary Care – A Clinical And Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00
  • Do Payers Equally Value the Cost Per Month of Overall Survival for Metastatic Castration Resistant Prostate Cancer within the Eu5?

    Nov 1, 2015, 00:00
  • Health Related Quality Of Life In Tb Patients Quetta, Pakistan

    Nov 1, 2015, 00:00
  • Comparative Effectiveness on Cardiovascular Outcomes of Metformin Initial Therapy and Add-on Second-Line Drugs Among Patients with Type 2 Diabetes

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis Of Phid-Cv Routine Vaccination Programme Compared To Pcv-13 In Portugal

    Nov 1, 2015, 00:00
  • Persistence to Therapy and the Associated Risk of Fractures with Antiosteoporotic Drugs

    Nov 1, 2015, 00:00
  • Do Clinical Guidelines for Hernia Surgery Reduce Costs and Improve Patient Outcomes, and Do Surgeons Follow Them?

    Nov 1, 2015, 00:00
  • Economic Analysis Of Cost Of Drug Treatment Involved In The Maintainance Therapy Of Copd

    Nov 1, 2015, 00:00
  • Conditional Agreements For Innovative Therapies In Italy- The Case Of Pirfenidone

    Nov 1, 2015, 00:00
  • Systematic Review Of Cost Effectiveness Of Ultra-Orphan Therapies

    Nov 1, 2015, 00:00
  • COST-EFFECTIVENESS ANALYSIS ON STARTING PATIENTS WITH CHRONIC MYELOID LEUKEMIA ON A HIGHLY POTENT TYROSINE KINASE INHIBITOR AND EARLY SWITCHING TO IMATINIB

    Nov 1, 2015, 00:00
  • Assessing Pharmaceuticals with Limited Evidence in Germany – Current Experience

    Nov 1, 2015, 00:00
  • The Budget Impact of Denosumab in the Treatment of Giant Cell Tumor of the Bone (Gctb) in Belgium

    Nov 1, 2015, 00:00
  • Prostatectomy- a Comparison of Cost-Benefit Analysis Between Open Surgery and Robotic Techniques

    Nov 1, 2015, 00:00
  • Is Nice Too Optimistic About Savings From Faecal Calprotectin Testing?

    Nov 1, 2015, 00:00
  • Oral Vinorelbine Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First-Line Treatment for Patients with Advanced non- Squamous non- Small Cell Lung Cancer- a Cost Minimization Analysis in Twelve European Countries

    Nov 1, 2015, 00:00
  • A Cost-Utility Analysis Of Nab-Paclitaxel (Abraxane) Plus Gemcitabine In Metastatic Pancreatic Cancer In Slovak Republic

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Sofosbuvir and Ledipasvir In The Treatment of Patients With Hepatitis C

    Nov 1, 2015, 00:00
  • Real-World Analysis Of Tyrosin Kinase Inhibitor Treatemnt Patterns Among Patients With Chronic Myeloid Leukemia In Korea

    Nov 1, 2015, 00:00
  • Drug Utilisation And Healthcare Resources Use In Patients With Psoriatic Arthritis And Psoriasis

    Nov 1, 2015, 00:00
  • Value Judgment of Health Interventions From Different Perspectives- Arguments and Criteria

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis Of Panitumumab + Folfox Compared To Cetuximab + Folfiri As First-Line Treatment For Patients With Wild-Type (Wt) Ras (Exons 2, 3, And 4 Of Kras And Nras) Metastatic Colorectal Cancer (Mcrc) In Colombia

    Nov 1, 2015, 00:00
  • Early Economic Evaluation of A Hypothetical Perfect Test for Predicting The Effectiveness of Implantable Pacemaker-Defibrillator Devices (Crt-D) In Patients With Heart Failure

    Nov 1, 2015, 00:00
  • Objective Data In Parkinson’s Disease Therapy Management – A Retrospective Analysis Of The Parkinson’s Kinetigraph (Pkg) Database

    Nov 1, 2015, 00:00
  • Exenatide Once Weekly Plus Metformin for the Treatment of Type 2 Diabetes Mellitus- A Network Meta-Analysis of Randomised Controlled Trials

    Nov 1, 2015, 00:00
  • Critical Appraisal Of Real World Evidence – A Review Of Recommended And Commonly Used Tools

    Nov 1, 2015, 00:00
  • Generic Drugs Adoption In Turkish Healthcare System

    Nov 1, 2015, 00:00
  • A Literature Study About Utilization of Oriental Medical Services

    Nov 1, 2015, 00:00
  • Challenges and Benefits of Conducting Value of Information Analysis from the Perspective of Industry- A Simulation Study

    Nov 1, 2015, 00:00
  • Breast Cancer in Brazil- Hospitalization Costs

    Nov 1, 2015, 00:00
  • Compliance with the Recently Introduced System of Generic Substitution and Reference Pricing in Ireland; Implications for Further Policy Rollout

    Nov 1, 2015, 00:00
  • The Use Of Social Media To Generate Health Data For Effectiveness Research- A Scoping Review

    Nov 1, 2015, 00:00
  • Skin Whitening Multiple Emulsions Loaded with Green Tea and Lotus Extracts- an Efficacy Study

    Nov 1, 2015, 00:00
  • Telemedicine Compared With Standard Care In Type 2 diabetes mellitus. A randomized Controlled Project In An Outpatient Clinic

    Nov 1, 2015, 00:00
  • Subjective Outcomes With Bone Conduction and Middle Ear Implants for Patients Wth Conductive or Mixed Hearing Loss

    Nov 1, 2015, 00:00
  • Cost Distribution Analysis Related to the Use of Tyrisine-Kinase Inhibitors (Tki) and the Combination of Pemetrexed/Cisplatin in the Treatment of Non-Small Cell Lung Cancer (Nsclc) Locally Advanced or Metastatic in Presence of Epidermal Gro ...

    Nov 1, 2015, 00:00
  • Economic Sanctions And Market Access for Pharmaceuticals- Case Studies With Russia, Cuba And Iran

    Nov 1, 2015, 00:00
  • Economic Evaluation of Tocilizumab Monotherapy Vs Adalimumab Monotherapy In Patients With Rheumatoid Arthritis In Italy

    Nov 1, 2015, 00:00
  • Effects of Nutritional Supplement Usage on Mortality In Patient Underwent Abdominal Resection Surgery for Non-Oncological Conditions

    Nov 1, 2015, 00:00
  • Implicaç’es Entre os Gastos Com a Produção Ambulatorial em Média Complexidade E À Atenção Básica

    Nov 1, 2015, 00:00
  • Development of Ms Budget Manager- A Practical Tool to Assist Alternative Stakeholders At Multiple Decision Levels In The Forecast And Financial Management For Multiple Sclerosis (Ms)

    Nov 1, 2015, 00:00
  • The Impact of Severe Asthma on the Quality of Life- a Systematc Review

    Nov 1, 2015, 00:00
  • Observational Study of Resource use and Cost of Alzheimer’s Disease in Europe (Geras) - 18-Month Results from the French Cohort

    Nov 1, 2015, 00:00
  • Evolution Influence of HTA in Emerging Markets

    Nov 1, 2015, 00:00
  • Campañas de Medicamentos; Instrumento Publicitario Que Atenta Contra Los Genéricos y el Acceso a Medicamentos

    Nov 1, 2015, 00:00
  • A Systematic Literature Review to Assess the Impact of Social Networks on Healthcare in India

    Nov 1, 2015, 00:00
  • Subject Recommendations for Improving Their Compliance and Engagement in Completing Daily Electronic Diaries in Osteoarthritis Clinical Trials

    Nov 1, 2015, 00:00
  • Applying Weighted Cumulative Exposure Models to Patterns of Nonspecific Symptom Consultations for Early Diagnosis- A Primary Care Database Study of Knee Pain and Osteoarthritis

    Nov 1, 2015, 00:00
  • Evaluation Analysis of Smoking Population in Ulaanbaatar

    Nov 1, 2015, 00:00
  • Trends In Emergency Room Visits Due To Hyperkalemia In The United States

    Nov 1, 2015, 00:00
  • Costs Of Septic Shock In England, Wales And Northern Ireland In 2012

    Nov 1, 2015, 00:00
  • Rituximab Sc Vs Rituximab Iv for non-Hodgkin’s Lymphomas (Nhls)- an Economic Evaluation for the Greek Healthcare System

    Nov 1, 2015, 00:00
  • How Has The Smc Patient And Clinician Engagement (Pace) Process Been Used In Assessments Of End-Of-Life Medicines And Medicines To Treat Very Rare Conditions?

    Nov 1, 2015, 00:00
  • Analysis Of Breast Cancer Patients’ Clinical Pathway Being Diagnosed By Mammography Breast Screening Program

    Nov 1, 2015, 00:00
  • Characteristics of Patients Starting Biologic Treatments for Rheumatoid Arthritis in The Real World- Systematic Review

    Nov 1, 2015, 00:00
  • Nordic Longitudinal Data from Electronic Medical Records and Full Population National Registers- Unique Opportunities for New Insights in Benefit of Diabetes Patients

    Nov 1, 2015, 00:00
  • Characteristics of Patients With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Agents

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Pembrolizumab for Unresectable Metastatic Melanoma After Progression with Ipilimumab in England

    Nov 1, 2015, 00:00
  • Hospital Costs Of Contrast-Induced Nephropathy

    Nov 1, 2015, 00:00
  • 18th Euro Abstracts - Financial Disclosure Statement

    Nov 1, 2015, 00:00
  • Healthcare Costs In Psoriatic Arthritis Patients Newly Initiated on Apremilast or Biologic Therapies

    Nov 1, 2015, 00:00
  • Economic Evaluation Of Individually Vs Vial-Packaged Strips For Glucose Monitoring

    Nov 1, 2015, 00:00
  • Budget Impact Analysis Of N-Terminal Pro-B-Type Natriuretic Peptide Testing For The Diagnosis And Prognosis Of Heart Failure In Greece

    Nov 1, 2015, 00:00
  • Treatment Costs In Primary And Secondary Healthcare In Finland

    Nov 1, 2015, 00:00
  • Individual and Societal Burden of Non-Adherence to Antidepressants in Brazil

    Nov 1, 2015, 00:00
  • Adapalene 0.1% / Benzoyl Peroxide 2.5% + Doxycycline 200mg Is A Less Expensive Alternative Compared to Oral Isotretinoin for The Management of Severe Nodular Acne In Sweden

    Nov 1, 2015, 00:00
  • Health Care Cost and Utilization Associated With Alpha-1 Antitrypsin Deficiency Among A Cohort of Medicare Beneficiaries With Copd

    Nov 1, 2015, 00:00
  • An Economic Evaluation to Assess the Cost Effectiveness of the New Medicine Service in Improving Adherence in People Initiated on New Treatment for Gout

    Nov 1, 2015, 00:00
  • Pharmacoeconomic Evaluation Of The Use Of Trastuzumab For Subcutaneous Administration Compared To Intravenous Dosage Form In The Treatment Of Breast Cancer

    Nov 1, 2015, 00:00
  • Systematic Literature Review of Health-Related Quality of Life In Patients Receiving Parenteral Nutrition

    Nov 1, 2015, 00:00
  • Do evidence review groups bias nice decisions?

    Nov 1, 2015, 00:00
  • Cost Analysis of The Chronic Hcv-Related Cirrhosis In Bulgaria

    Nov 1, 2015, 00:00
  • Exploring Variation in Cost-Effectiveness Estimates in Studies that Evaluate Adult Pneumococcal Vaccination in Latin America

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of Ofatumumab Plus Chlorambucil In First-Line Chronic Lymphocytic Leukemia In The United Kingdom

    Nov 1, 2015, 00:00
  • Cost of Cervical Cancer and Cervical Intraepithelial Neoplasia in Croatia

    Nov 1, 2015, 00:00
  • Implementation of Population Dynamics In Modelling Health And Budget Impact of An Intervention for A Chronic Disease With Multiple Disease Subtypes

    Nov 1, 2015, 00:00
  • Leptospirosis; A Zoonotic, Morbid and Fatal Disease- A Record Viewing Study

    Nov 1, 2015, 00:00
  • Alternatives To Winbugs for Network Meta–Analysis

    Nov 1, 2015, 00:00
  • The Ceesp Economic Evaluation- Can Clinical Efficacy and Cost-Effectiveness Co-Exist in France

    Nov 1, 2015, 00:00
  • Testing for Ns5a Resistance in Order to Optimize Antiviral Therapy With Simeprevir And Sofosbuvir 12 Weeks Appears Cost-Effective in Non-Cirrhotic Genotype 1 Hepatitis C Virus Treatment Experienced Patients

    Nov 1, 2015, 00:00
  • Characteristics and Outcomes of Patients with Dengue Viral Infection During The Hospitalization At Tertiary Care Hospital

    Nov 1, 2015, 00:00
  • Evaluation of The Burden of Parkinson’s Disease In Medicare And Linked Long Term Care Population

    Nov 1, 2015, 00:00
  • Cost Analysis Study of Anti-Diabetic Fixed Dose Combination Drugs- An Indian Scenario

    Nov 1, 2015, 00:00
  • Organs-On-Chips- Exploring The Utility Of Biosynthesised Organ Tissue To Improve Efficiency Of The Drug Development Process

    Nov 1, 2015, 00:00
  • Character of Toxic Damage of Liver In Influences of Substances of Mediator to Fetal Cells on Hepatocytes In Acute Liver Failure

    Nov 1, 2015, 00:00
  • Perfil Alimentario Según Estado Nutricional De Estudiantes Universitarios De Valparaiso, Chile

    Nov 1, 2015, 00:00
  • Diálise Planejada E A Utilização Regular Da Atenção Primária À Saúde Entre Os Pacientes Diabéticos Do Município De Belo Horizonte, Minas Gerais, Brasil

    Nov 1, 2015, 00:00
  • What Makes A Pharmaceutical Pricing Reimbursement Process Patient-Centric? A Comparative Analysis Of 11 Systems

    Nov 1, 2015, 00:00
  • Access To The Procedure Care of Colorectal Cancer In Brazilian Public Health System- Use Of Diagnosis Resources In São Paulo State

    Nov 1, 2015, 00:00
  • Valuation of the Eq-5d-5l with Composite Time Trade-off for the German Population

    Nov 1, 2015, 00:00
  • Cholic Acid Decreases the Distribution Coefficient of Simvastastin- A Potential for Increasing Simvastatin Bioavailability

    Nov 1, 2015, 00:00
  • Public Consultations- A Tool for the Inclusion of Society in the Brazilian Hta Process

    Nov 1, 2015, 00:00
  • Availability Of Drugs Recommended By Global Initiative For Chronic Obstructive Lung Disease (Gold) For Ukrainian Patients With Copd

    Nov 1, 2015, 00:00
  • Cost-Utility Analysis of Natalizumab as First-Line Treatment of Highly-Active Relapsing-Remitting Multiple Sclerosis in the Brazilian Public Healthcare System

    Nov 1, 2015, 00:00
  • Review Of Us Medicare System For Reimbursement Of New Medical Devices

    Nov 1, 2015, 00:00
  • Pharmaceutical Cost-Containment Strategies – Opinions of the Pharmaceutical Industry and Hta Bodies in Latin America

    Nov 1, 2015, 00:00
  • National Study to Assess The Costs of Patients With High Myopia With and Without Choroidal Neovascularisation

    Nov 1, 2015, 00:00
  • Cost-Utility Analysis of Certolizumab Pegol for the Treatment of Active Psoriatic Arthritis in GREECE

    Nov 1, 2015, 00:00
  • Assessment of Drug Use Pattern Using Who Prescribing And Patient Care Indicators In A Referral Hospital In Ethiopia

    Nov 1, 2015, 00:00
  • Clinical Effectiveness And Safety Of Robot-Assisted Laparoscopic Hysterectomy Versus Traditional Laparotomy For Endometrial Cancer- A Systematic Review

    Nov 1, 2015, 00:00
  • Interpreting Results from Bayesian Network Meta-Analyses (Nma)- A Guide for Non-Statisticians

    Nov 1, 2015, 00:00
  • Prevalence and Incidence of Malnutrition Among Geriatrics Population in Turkey

    Nov 1, 2015, 00:00
  • The Importance of Accounting for Baseline Hypoglycaemia Frequency When Modelling Hypoglycaemia Disutility In Type 1 Diabetes Mellitus

    Nov 1, 2015, 00:00
  • Budget Impact Analysis of An Etanercept Biosimilar for The Treatment of All Licensed Etanercept Indications for Adults In Europe

    Nov 1, 2015, 00:00
  • Benefit-Risk of Vka for Atrial Fibrillation Before Doac- a Cohort Study in a Claims and Hospitalization Database

    Nov 1, 2015, 00:00
  • A Cost-Effectiveness Analysis of Hospital Pharmacist Review in Older Patients

    Nov 1, 2015, 00:00
  • Comparison Of Treatment-Related Adverse Events Recorded In Administrative Claims Data With Those Recorded In Electronic Medical Records For Multiple Myeloma Patients

    Nov 1, 2015, 00:00
  • Investigating The Relationship Between “Severity Of Illness” And The “Modified Rankin Scale” In Ischemic Stroke Patients With Response Mapping

    Nov 1, 2015, 00:00
  • Quality of Life Issues Important to Patients with Haematological Malignancies

    Nov 1, 2015, 00:00
  • A Study On Cytogenetic And Molecular Analysis Of Presenilin 1 (Ps1) Gene In Alzheimer’s Disease

    Nov 1, 2015, 00:00
  • Epidemiology and Costs of Peripheral Arteriopathy In Diabetic Patients- A Population-Based Study

    Nov 1, 2015, 00:00
  • Adherence to Inhaled Antibiotics for The Treatment of Chronic Pseudomonas Aeruginosa Infection In Patients With Cystic Fibrosis- A Systematic Literature Review

    Nov 1, 2015, 00:00
  • Estimation of The Relative Efficacy of Licensed Regimens for Genotype-1 Hcv Infection Using A Mixed Treatment Comparison

    Nov 1, 2015, 00:00
  • Clinical Characteristics, Lipid Treatment and Goal Attainment in a Familial Hypercholesterolemia Cohort in The Netherlands- a Cross Sectional Study

    Nov 1, 2015, 00:00
  • Ultra Orphan and Cancer Drug Pricing Trends In The Us and The Uk

    Nov 1, 2015, 00:00
  • Developing and Validating a New Tool- Physicians’ Barriers, Attitudes and Practices Towards Applying Smoking Cessation Interventions in Their Clinics

    Nov 1, 2015, 00:00
  • Cost of Illness (Out of Pocket Costs Paid By Patient) for T.B in Quetta City, Pakistan

    Nov 1, 2015, 00:00
  • Hrqol And Utility In Nocturia Are Correlated To Number Of Voids

    Nov 1, 2015, 00:00
  • Reliability of Manufacturers’ Budget Impact Estimates for Severe Rheumatoid Arthritis Drugs in Poland

    Nov 1, 2015, 00:00
  • Health Economics And Radium-223 (Xofigo®) In The Treatment Of Metastatic Castration-Resistant Prostate Cancer (Mcrpc). A Case History And A Systematic Review Of The Literature On Cost-Effectiveness Analysis (Cea)

    Nov 1, 2015, 00:00
  • Critical Analysis of Pricing and Reimbursement Process on The Basis of New Indroduced Pharmacoeconomic Guidelines In Bulgaria

    Nov 1, 2015, 00:00
  • Utilizacion De Servicios De Salud Para El Tratamiento De Cáncer De Estomago En Venezuela

    Nov 1, 2015, 00:00
  • Measuring the Importance of Decision Making Criteria for Anticancer Drug Reimbursement in Korea

    Nov 1, 2015, 00:00
  • Management Of Soft Tissue Sarcoma (Sts) In France - A Retrospective Analysis Of The French Clinical Biological Sarcoma Database (Gsf-Geto)

    Nov 1, 2015, 00:00
  • Rapid Increase of Health Litigation As A Means of Market Access For Innovative Medicines In Colombia And The Potential Role Of Health Technology Assessment

    Nov 1, 2015, 00:00
  • The cancer drugs fund in england – undermining nice or efficient and good value for money?

    Nov 1, 2015, 00:00
  • Impact of Ongoing National Health Technology Assessment Challenges on Patient Access to New Therapies for Multiple Sclerosis In Germany And The Uk

    Nov 1, 2015, 00:00
  • Forecasting The Prevalence of Status Epilepticus and Its Subtypes In Europe, 2015–2024

    Nov 1, 2015, 00:00
  • The Devil Is Not So Black As He Is Painted – The Future of Immunization In Poland

    Nov 1, 2015, 00:00
  • To What Extent Do Payers’ Assessment Of Clinically Relevant Outcomes Align With Clinicians In Oncology?

    Nov 1, 2015, 00:00
  • Health Technology Assessment Needs Information Technology- The Experience From The First Italian Study On The Da Vinci Surgical Robot

    Nov 1, 2015, 00:00
  • Idiopathic Pulmonary Fibrosis- Hospital Disease Management and Associated Costs

    Nov 1, 2015, 00:00
  • A Streamlined Approach to Ethics Review in Brazil

    Nov 1, 2015, 00:00
  • Surgery As An Outcome In Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00
  • A Five Years Budget Impact Analysis of The Introduction of Adalimumab For Crohn’s Disease Patients From The Perspective of The Brazilian Private Health Care System

    Nov 1, 2015, 00:00
  • Comparison of Patient-Reported Outcomes Requirements in Medical Guidelines for Pain, Migraine, Rheumatoid Arthritis, and Systemic Lupus Erythematosus- Europe Vs. United States

    Nov 1, 2015, 00:00
  • The Cost-Effectiveness Of Bariatric Surgery In Germany

    Nov 1, 2015, 00:00
  • Number of Osteoporosis Patients with Pathological Fractures by Months in Outpatient Care in the Light of Physiotherapy Care in Hungary

    Nov 1, 2015, 00:00
  • Potential Savings To Eu Economy Due To Returning To Work Of Cancer Survivors With A Disability

    Nov 1, 2015, 00:00
  • Budget impact analysis of drug coated balloon vs. Percutaneous transluminal balloon angioplasty in the treatment of peripheral arterial disease in lower limbs in brazil

    Nov 1, 2015, 00:00
  • Early Benefit Assessment And Uptake Of Pharmaceutical Innovations – Experiences From Germany 2011 To 2014

    Nov 1, 2015, 00:00
  • Do Clinical Guideline Implementations Reduce The Government Budget? A Clinical Guideline-Based Budget Impact Model In Reimbursement Of Inhaler Treatments In Copd

    Nov 1, 2015, 00:00
  • 36 Months Pangaea- A 5-Year Non-Interventional Study of Safety, Efficacy and Pharmacoeconomic Data for Fingolimod Patients In Daily Clinical Practice

    Nov 1, 2015, 00:00
  • Avoidable Hospitalizations Due To Medication Errors In Belgium

    Nov 1, 2015, 00:00
  • Trends In Self-Rated Health Status Among Adults In Greece (2002-2015)

    Nov 1, 2015, 00:00
  • Examining Prescribing Patterns in Older Patients with Acute Illness

    Nov 1, 2015, 00:00
  • Percentage Price Variation Among Antidepressant Drugs in Indian Market- an Economic Perspective

    Nov 1, 2015, 00:00
  • Perfil Del Gasto De Bolsillo En Medicamentos Esenciales En Panamá, 2014

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Zoledronic Acid Versus Alendronic Acid In The Treatment of Osteoporosis In Postmenopausal Egyptian Patients- Decision Analysis

    Nov 1, 2015, 00:00
  • The Impact of Social Networks on The Students Health

    Nov 1, 2015, 00:00
  • Jósa András Hospital Complex Project - Cost-Benefit Analysis Of The Major Project Investment

    Nov 1, 2015, 00:00
  • Factors Associated with T2DM Treatment Choice Across Europe

    Nov 1, 2015, 00:00
  • Patient Diagnostic Therapeutic Pathway For Patients With Psoriasis The Organisational Analysis of 13 Excellence Centres Of The Tuscany Region (Italy)

    Nov 1, 2015, 00:00
  • Prevalence Of Switching From Brand To Generic Asthma Medications

    Nov 1, 2015, 00:00
  • The Effect Of A Telephone Counseling Intervention By Pharmacist On Patients’ Beliefs About Medicines And Blood Pressure Control

    Nov 1, 2015, 00:00
  • Clustering Health Status Among Adults With Hemophilia Using Sf-12 Health Survey

    Nov 1, 2015, 00:00
  • Direct Costs And Healthcare Resource Use Associated With Advanced Melanoma In Portugal

    Nov 1, 2015, 00:00
  • Cost of Illness Study of Type 2 Diabetes Mellitus in the Newly Established Diabetology Outpatient Facility in the Czech Republic

    Nov 1, 2015, 00:00
  • Novel Oral Anticoagulant Use In The Eu5- How Are Payer Policies And Physician Preferences Shaping The Prescribing Landscape?

    Nov 1, 2015, 00:00
  • Medical Device Reimbursement Rules In Turkey- With Past And Current Practices, Looking Forward

    Nov 1, 2015, 00:00
  • Diabetes Duration and Severity and Labour Market Outcomes In Mexico

    Nov 1, 2015, 00:00
  • Study Of Knowledge, Attitude And Practice Of General Population Of Guntur Towards Silent Killer Diseases - Hypertension And Diabetes

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Biologics Compared to Conventional Disease-Modifying Antirheumatic Drugs for Treatment of Rheumatoid Arthritis in Finland

    Nov 1, 2015, 00:00
  • A Conceptual Paper on Steps Needed to Reach Integrated Healthcare System In Egypt

    Nov 1, 2015, 00:00
  • Off-Label Use of Intravenous Immunoglogulins (IVIGS)- Funding Mechanisms in France, Germany, Italy, Spain and the United Kingdom (EU5)

    Nov 1, 2015, 00:00
  • Colonrectal Cancer Evaluation Of Italian Screening And Mortality

    Nov 1, 2015, 00:00
  • The British Isles Hta League Table 2014

    Nov 1, 2015, 00:00
  • Standards Of Surgical Materials Usage In Anterior Cruciate Ligament (Acl) Surgery In Brazil Under The Perspective Of The Private Health Care System

    Nov 1, 2015, 00:00
  • Cart Analysis As A Tool To Determine Optimal Treatment Intensification Time In Diabetes

    Nov 1, 2015, 00:00
  • Patient-Centered Reasons for Primary Non-Adherence as Derived from the Peer-Reviewed Literature

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis of Canacinumab In The Treatment of Patients Suffering From Systemic Juvenile Idiopathic Arthritis In Russian Federation

    Nov 1, 2015, 00:00
  • Laparoscopic Surgery Versus Traditional Open Surgery For Kidney Implantation- A Cost-Effectiveness Model

    Nov 1, 2015, 00:00
  • Health Economic Programming Using Royston-Parmar “Hazard Rate” Models- Providing Flexibility and Speed for Event Modelling In Cohort and Des Models

    Nov 1, 2015, 00:00
  • Adverse Events Costs Associated With Erlotinib Or Afatinib In Non-Small Cell Lung Cancer (Nsclc) Patients With Egfr Mutation-Positive Tumours

    Nov 1, 2015, 00:00
  • Development of A Validated Questionnaire Evaluating The Burden of The Haemorrhoidal Disease and Anal Fissure (Hemo-Fiss)

    Nov 1, 2015, 00:00
  • Willing to Provide Medication Analysis? Predicting Pharmacists’ Intention to Provide Medication Analysis In Community Pharmacies In Germany

    Nov 1, 2015, 00:00
  • Comparative Effectiveness of Ticagrelor Vs. Prasugrel in Patients with Acute Coronary Syndrome

    Nov 1, 2015, 00:00
  • A Prospective Prescription Cost Analysis of Asthma Medication

    Nov 1, 2015, 00:00
  • Patterns of Care with Biological Drugs for Ankylosing Spondylitis- Real-World Data from the Private Healthcare Market in Brazil

    Nov 1, 2015, 00:00
  • Patient Versus General Population Health State Valuations- A Case Study Of Low Back Pain

    Nov 1, 2015, 00:00
  • Development of A Screening Tool to Support Identification of Patients With Secondary Progressive Multiple Sclerosis (Spms)

    Nov 1, 2015, 00:00
  • Understanding The Inter-Relationship Between Improved Glycaemic Control, Hypoglycaemia and Weight Change Within A Type 1 Diabetic Population

    Nov 1, 2015, 00:00
  • Hrqol And Health Utility Impact On Patients With Newly Diagnosed Multiple Myeloma In Us And Europe- A Systematic Literature Review

    Nov 1, 2015, 00:00
  • Real-World Medical Costs of Antiviral Therapy Among Patients With Chronic Hcv Infection and Advanced Hepatic Fibrosis

    Nov 1, 2015, 00:00
  • Clinical and Economic Burden of Prostate Cancer

    Nov 1, 2015, 00:00
  • Pharmacoeconomics Of Ruxolitinib Therapy In Patients With Myelofibrosis

    Nov 1, 2015, 00:00
  • Costs of Type 1 Diabetes Mellitus in Pediatric Patients in Spain- Chrystal Observational Study

    Nov 1, 2015, 00:00
  • Can Actigraphy Outcome Measures From Existing Clinical Trials Provide A Framework for Sleep and Activity Endpoint Standards in the Clinical Trial of the Future?

    Nov 1, 2015, 00:00
  • Investigation of the Living and its Impact to the Pregnants

    Nov 1, 2015, 00:00
  • The Value Of Progression-Free Survival (Pfs) As An Endpoint In Oncology Trials

    Nov 1, 2015, 00:00
  • Epidemiology of Hepatitis C Patients In Italian Local Health Units (Lhus)

    Nov 1, 2015, 00:00
  • ESTIMATION OF THE TRESHOLD PRICE OF REGORAFENIB IN THE TREATMENT OF UNRESECTABLE AND/OR METASTATIC GASTROINTESTINAL STROMAL TUMORS AFTER FAILURE ON IMATINIB AND SUNITINIB IN SPAIN- COST-UTILITY ANALYSIS

    Nov 1, 2015, 00:00
  • Economic Assessment of Eribulin Against Treatment of Physician’s Choice (Tpc) in Taiwan

    Nov 1, 2015, 00:00
  • The Intertemporal Changes Of Health Services Utilization During The Last Decade- The Case Of Austerity Inflicted On Greece

    Nov 1, 2015, 00:00
  • Access to Innovative Drugs in Patients with Metastatic Lung Cancer in French Public Hospitals (the Territoire Study)

    Nov 1, 2015, 00:00
  • Quantitative Assessment of Therapeutic Value of Innovative Medical Technologies- Methodology and Preliminary Results

    Nov 1, 2015, 00:00
  • Avaliação De Tecnologias No Tratamento Da Depressão Maior- Overview Sobre A Eficácia E Segurança Da Duloxetina, Venlafaxina E Trazodona Comparados À Fluoxetina

    Nov 1, 2015, 00:00
  • Using Machine Learning to Detect Patients With Undiagnosed Rare Diseases- An Application of Support Vector Machines to A Rare Oncology Disease

    Nov 1, 2015, 00:00
  • Can Qva149 Improve Short Term Outcomes In Patients With Copd Without Increasing The Overall Treatment Costs For The Portuguese Nhs? Optimizing Treatment Outcomes With A Responsible Use Of Limited Resources

    Nov 1, 2015, 00:00
  • Modelling to Determine the Price and Identify Critical Data Gaps During Vaccine Development

    Nov 1, 2015, 00:00
  • Improving Patient Quality of Life By Verifying And Enhancing Quality of Orthopaedic And Prosthetic Medical Devices

    Nov 1, 2015, 00:00
  • Eunethta Tools and Methods – Facilitating Uptake by Training Activities

    Nov 1, 2015, 00:00
  • Economic Impact of Employment Status on The Social Cost of Morbid Obese Patients Submitted to Bariatric Surgery

    Nov 1, 2015, 00:00
  • Assessing the Cost-Effectiveness of Therapies in the Third Quadrant on the Cost-Effectiveness Plane

    Nov 1, 2015, 00:00
  • Higher Accuracy Of Blood Glucose Monitoring Systems In Type 2 Insulin Treated Diabetic Patients In Spain- Clinical And Economic Impact

    Nov 1, 2015, 00:00
  • The Esmo Magnitude of Clinical Benefit Scale for Novel Cancer Medicines — Correspondence with Prioritization Decisions In Updating the Israeli National List of Health Services

    Nov 1, 2015, 00:00
  • Determinantes Socioeconómicos De La Obesidad En Escolares Y Adolescentes En Colombia- Un Análisis Regional

    Nov 1, 2015, 00:00
  • Simulation optimisation of Treatment Sequences for Rheumatoid arthritis

    Nov 1, 2015, 00:00
  • Overview of Generics Policies and Penetration in Japan

    Nov 1, 2015, 00:00
  • Budget Impact Analysis of the Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors – Nilotinib in the First and Second Lines of Therapy

    Nov 1, 2015, 00:00
  • «
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87 (current)
  • 88
  • 89
  • 90
  • »